Ddx21 mutant peptide is an effective neoantigen in prophylactic lung cancer vaccines and activates long-term anti-tumor immunity - Zhang, Zhe; Xia, Yimeng; Wang, Zhihong; Sun, Yaxing; Pu, Dan; He, Yijia; Liu, Ruixian; Zhang, Yanru; Liu, Yan; Yu, Junzhi; Ning, Shiyang; Feng, Baisui; et al. (Frontiers in Immunology, 2025)